Review Article
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
Table 5
Protection of anti-Parkinson’s drugs in T2DM.
| LEVODOPA | BROMOCRPTINE |
| No | Yes | Human trials: Cereda et al. [71], Rosati et al. [73] | Human trials Chamarthi et al. [74] Roe et al. [75], Ghosh et al. [76], Gaziano et al. [77], Vinik et al. [78], Pijl et al. [79] | | Animal studies: Ezrokhi et al. [80], Luo et al. [81], Luo et al. [82], Cincotta et al. [83] |
|
|